MAFA
PFE icon

MJT & Associates Financial Advisory’s Pfizer PFE Stock Holding History

MJT & Associates Financial Advisory’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.77K Hold
115
– – ﹤0.01% 357
2026
Q1 		$3.23K Hold
115
– – ﹤0.01% 326
2025
Q4 		$2.86K Hold
115
– – ﹤0.01% 360
2025
Q3 		$2.93K Hold
115
– – ﹤0.01% 360
2025
Q2 		$2.79K Hold
115
– – ﹤0.01% 374
2025
Q1 		$2.92K Buy
+115
New +$3.01K ﹤0.01% 368

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MJT & Associates Financial Advisory's PFE Position: Q2 2026 in Review

MJT & Associates Financial Advisory held its Pfizer (PFE) position steady in Q2 2026 at 115 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #357.

MJT & Associates Financial Advisory first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.23K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MJT & Associates Financial Advisory held 115 shares of Pfizer worth $2.77K as of Q2 2026.
  • MJT & Associates Financial Advisory left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of MJT & Associates Financial Advisory's portfolio in Q2 2026, its #357 holding.
  • MJT & Associates Financial Advisory first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • MJT & Associates Financial Advisory's Pfizer position peaked at $3.23K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q2 2026, filed 6 Jul 2026.